Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Pyridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL3986375 | 0.91 | TDP1 (0.50) | TSHRNAPRTTDP1CHRNB2CHRNA4 | |
| Pyridine SCHEMBL290841 | 0.88 | TDP1 (0.53) | TSHRNAPRTTDP1CHRNB2CHRNA4 | |
| Pyridine SCHEMBL28136040 | 0.87 | HTT (0.32) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL8356836 | 0.84 | TDP1 (0.43) | TSHRNAPRTTDP1CHRNB2CHRNA4 | |
| Pyridine SCHEMBL26930 | 0.83 | — | — | |
| Pyridine SCHEMBL16048785 | 0.83 | TSHR (0.60) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL9655437 | 0.81 | TSHR (0.45) | TSHRNAPRTTDP1CHRNB2CHRNA4 | |
| Pyridine SCHEMBL6290122 | 0.80 | TSHR (0.56) | TSHRNAPRTTDP1 | |
| Pyridine SCHEMBL7695535 | 0.80 | TSHR (0.56) | TSHRNAPRTTDP1MAPT | |
| Pyridine SCHEMBL28346173 | 0.80 | TSHR (0.56) | TSHRNAPRTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-04-06 | — | — | US | disclosed |
| US-11162952-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2021-11-02 | — | — | US | disclosed |
| US-10545153-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-01-28 | — | — | US | disclosed |
| US-20170276686-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2017-09-28 | — | — | US | disclosed |
| EP-2766389-B1 | GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN | SANOFI SA (FR) | 2017-03-29 | — | — | EP | disclosed |
| US-9422566-B2 | Gene cluster for biosynthesis of griselimycin and methylgriselimycin | SANOFI (FR) | 2016-08-23 | — | — | US | disclosed |
| US-20140295457-A1 | GENE CLUSTER FOR BIOSYNTHESIS OF GRISELIMYCIN AND METHYLGRISELIMYCIN | SANOFI (FR) | 2014-10-02 | — | — | US | disclosed |
| EP-2586791-A1 | Gene cluster for biosynthesis of griselimycin and methylgriselimycin | SANOFI (FR) | 2013-05-01 | — | — | EP | disclosed |
| US-7452701-B2 | Methods for the preparation of β-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-11-18 | — | — | US | disclosed |
| US-20080268510-A1 | METHOD FOR PRODUCING L-BETA-LYSINE | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-10-30 | — | — | US | disclosed |
| US-7354745-B2 | Method for producing L-β-lysine | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-04-08 | — | — | US | disclosed |
| WO-2004021981-A2 | METHODS FOR THE PREPARATION OF β-AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2004-03-18 | — | — | WO | disclosed |
| US-20030113882-A1 | Methods for the preparation of beta-amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2003-06-19 | — | — | US | disclosed |
| US-20020173637-A1 | Method for producing L-beta-lysine | WISCONSIN ALUMNI RESEARCH FOUNDATION (WARF). | 2002-11-21 | — | — | US | disclosed |
| US-6248874-B1 | EXPRESSION VECTORS FOR THE GENERATION OF ENZYMATIC PROTEIN | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | QPCTL, ANPEP, VIP | TSHR 3578/4885NAPRT 4566/4885TDP1 3386/4885 |
| US-11162952-B2 | Single molecule peptide sequencing | MICA, ANPEP, VIP | TSHR 4070/4885NAPRT 4286/4885TDP1 715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.